Location
United States, North America
Check Size
$100K - $5M
Investment Stage
Focus Areas
About Investor
David Goeddel is a Managing Partner at The Column Group, a venture capital firm that takes a novel approach to funding with an edge-to-edge investment model primarily focused on company formation but with the financial wherewithal for long-term private and public capital support. The firm typically invests between $100K and $5.0M, focusing on Seed through Series B stages in sectors including Consumer Health, Pharmaceuticals, BioTech, Health IT, Health & Hospital Services, and Digital Health. David, who previously served as Senior VP at Amgen, has been with The Column Group since 2006 and is known for his scientific expertise in molecular biology, having learned the emerging techniques in gene cloning and expression in the Dept. of Molecular Biology.
Previous investments
Similar Investors
Abdul Ly
Seed
,Series A
,Paul Straub
Pre Seed
,Seed
,Shaun Abrahamson
Pre Seed
,Seed
,Riley Florsheim
Pre Seed
,Seed
,Steve Brownlie
Pre Seed
,Seed
,Danielle Graham
Pre Seed
,Seed
,Is this You?
Is this you? Have any edits?
Fill out our update request form and we'll update ASAP
Grow with the Right Investors
This profile is just one example. Our AI matches you with the investors who best fit your stage, industry, and vision.
Start Matching For Free